Source: iQoncept / Shutterstock
Olema Pharmaceuticals (NASDAQ:OLMA) just reported results for the first quarter of 2024.
- Olema Pharmaceuticals reported earnings per share of -56 cents. This was below the analyst estimate for EPS of -51 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/olma-stock-earnings-olema-pharmaceuticals-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC